Real‐World Dosing and Persistence of Oral Treprostinil Initiation Strategies in Patients With Pulmonary Arterial Hypertension

ABSTRACT In patients with pulmonary arterial hypertension (PAH), limited real‐world data are available on persistence to oral treprostinil therapy, particularly while transitioning from parenteral prostacyclins. We compared persistence to oral treprostinil and total daily dose (TDD) achieved among p...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Daniel J. Lachant, Ali Ataya, H. James Ford III, Meredith Broderick, Scott Seaman, Benjamin Wu, Murali M. Chakinala
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Wiley 2025-10-01
Cyfres:	Pulmonary Circulation
Pynciau:	medication persistence oral treprostinil prostacyclin pulmonary arterial hypertension transition
Mynediad Ar-lein:	https://doi.org/10.1002/pul2.70227
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!